| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 80461 |
5-[4-(3,5-二-十二烷氧基苯甲酰亚胺基)苯基]-10,15,20-三苯基卟啉配体(DDTPP) |
111 |
WYQ |
2024-12-25 |
| 80462 |
cas:55750-62-4,3-(Maleimido)propionic acid N-hydroxysuccinimide ester |
172 |
h |
2024-12-25 |
| 80463 |
Meso-四(4-十四氨基甲酰苯基)卟啉(14AFPP) |
139 |
WYQ |
2024-12-25 |
| 80464 |
mPEG12-OH , 甲氧基十二聚乙二醇-羟基 |
174 |
wyh |
2024-12-25 |
| 80465 |
cas:1305053-43-3,15-(2-pyridyldithio)-4,7,10,13-tetraoxapentadecanoic acid N-hydroxysuccinimide ester |
114 |
h |
2024-12-25 |
| 80466 |
4-甲酰苯甲酸N-琥珀酰亚胺酯,60444-78-2,ADC试剂 |
194 |
hyy |
2024-12-25 |
| 80467 |
Meso-5,10,15,20-四(对氯苯基)卟啉;TP-ClPPH2 |
165 |
WYQ |
2024-12-25 |
| 80468 |
cas:317331‐86‐5,N-succinimidyl-5-(2-pyridyldithio)valerate |
145 |
h |
2024-12-25 |
| 80469 |
cas:663599-11-9,1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
145 |
h |
2024-12-25 |
| 80470 |
mPEG7-NH2,甲氧基七聚乙二醇-氨基 |
182 |
wyh |
2024-12-25 |
| 80471 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
171 |
WYQ |
2024-12-25 |
| 80472 |
N3-PEG4-C2-Pfp ester,1353012-00-6,抗体- 药物偶联物 |
109 |
hyy |
2024-12-25 |
| 80473 |
cas:341498-08-6,N-Succinimidyl 4-(2-pyridyldithio)pentanoate |
197 |
h |
2024-12-25 |
| 80474 |
mPEG16-NH2 ,cas:907577-50-8 ,甲氧基十六聚乙二醇-氨基 |
148 |
wyh |
2024-12-25 |
| 80475 |
cas:115088-06-7,N-Succinimidyl 4-(2-pyridyldithio)butanoate |
140 |
h |
2024-12-25 |
| 80476 |
mPEG48-Br,甲氧基四十八聚乙二醇溴代 |
119 |
wyh |
2024-12-25 |
| 80477 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
192 |
WYQ |
2024-12-25 |
| 80478 |
mPEG11-Br,溴代十一甘醇单甲醚 |
128 |
wyh |
2024-12-25 |
| 80479 |
NHS-PEG4-azide,叠氮-PEG4-NHS酯,944251-24-5 ,ADC试剂 |
131 |
hyy |
2024-12-25 |
| 80480 |
cas:1610769-13-5,4-((S)-2-((S)-2-amino-3- methylbutanamido)-5- ureidopentanamido)benzyl 2-(pyridin- 2-yldisulfanyl)ethylcarbamate |
136 |
h |
2024-12-25 |
| 80481 |
mPEG4-OCH2COOH的结构特点,16024-66-1 |
158 |
wyh |
2024-12-25 |
| 80482 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
117 |
WYQ |
2024-12-25 |
| 80483 |
四苯基钯卟啉(Pd TPP),卟啉类化合物 |
271 |
WYQ |
2024-12-25 |
| 80484 |
N3-PEG3-C2-NHS ester,1245718-89-1,抗体- 药物偶联物 |
119 |
hyy |
2024-12-25 |
| 80485 |
cas:2353409-52-4 Mal-amido-PEG8-val-gly-PAB-OH |
99 |
h |
2024-12-25 |
| 80486 |
mPEG24-NH-Mal ,甲氧基二十四聚乙二醇-NH-马来酰亚胺 |
115 |
wyh |
2024-12-25 |
| 80487 |
cas:330970-70-2 Alloc-Val-Ala-OH,抗体偶联药物 |
134 |
h |
2024-12-25 |
| 80488 |
mPEG3-SH ,甲氧基三聚乙二醇-巯基 |
134 |
wyh |
2024-12-25 |
| 80489 |
cas:150114-97-9 Fmoc-Val-Ala-OH,抗体偶联药物 |
149 |
h |
2024-12-25 |
| 80490 |
N3-PEG2-C2-NHS ester,1312309-64-0,ADC试剂 |
112 |
hyy |
2024-12-25 |
| 80491 |
Methyltetrazine-CH2NHCO-PEG12-CH2CH2NH2 |
119 |
zyl |
2024-12-25 |
| 80492 |
mPEG11-OH,甲氧基十一聚乙二醇-羟基 |
106 |
wyh |
2024-12-25 |
| 80493 |
cas:70396-18-8 Boc-Val-Ala-OH,抗体偶联药物 |
129 |
h |
2024-12-25 |
| 80494 |
cas:2348405-93-4 DBCO-PEG4-Val-Ala-PAB-PNP,抗体偶联药物 |
120 |
h |
2024-12-25 |
| 80495 |
mPEG5-OH , 甲氧基五聚乙二醇-羟基 |
110 |
wyh |
2024-12-25 |
| 80496 |
cas:2762519-08-2 endo-BCN-PEG4-Val-Cit-PAB-MMAE |
140 |
h |
2024-12-25 |
| 80497 |
Methyltetrazine-CH2NHCO-PEG7-CH2CH2NH2 |
105 |
zyl |
2024-12-25 |
| 80498 |
mPEG12-CH2C≡CH,单甲氧基十二聚乙二醇炔基 |
128 |
wyh |
2024-12-25 |
| 80499 |
Azido-PEG4-MMAE,抗体偶联药物 |
105 |
h |
2024-12-25 |
| 80500 |
FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne |
152 |
h |
2024-12-25 |
| 80501 |
Methyltetrazine-CH2NHCO-PEG2-CH2CH2NH2的介绍 |
163 |
zyl |
2024-12-25 |
| 80502 |
mPEG48-OCH2CH2COONHS Ester的结构特点 |
223 |
wyh |
2024-12-25 |
| 80503 |
cas:2226472-28-0 DBCO-PEG4-Val-Cit-PAB-PNP,抗体偶联药物 |
185 |
h |
2024-12-25 |
| 80504 |
endo BCN-PEG3-Val-Cit,抗体偶联药物 |
112 |
h |
2024-12-25 |
| 80505 |
4-Azido-2,3,5,6-tetrafluorobenzoic Acid N-Succinimidyl ester,126695-58-7,抗体- 药物偶联物 |
139 |
hyy |
2024-12-25 |